Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VERTEX PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: VRTX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.000 Buy 26
    30 Days Ago 2.136 Buy 22
    60 Days Ago 2.136 Buy 22
    90 Days Ago 2.136 Buy 22
    120 Days Ago 2.091 Buy 22
  • Analyst Ratings: VRTX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Deutsche Securities Buy 10/30/2009 39.00
    Wedbush Morgan Neutral 10/21/2009 42.00
    RBC Capital Mkts Outperform 10/09/2009
    Wedbush Morgan Buy 03/18/2009 38.00
    ThinkEquity Source of Funds Accumulate 03/04/2009 34.00
    ThinkEquity Source of Funds 01/27/2009 31.00
    Credit Suisse Outperform 11/25/2008 33.00
    Lazard Capital Hold 11/25/2008
    Merriman Curhan Ford Buy 11/20/2008
    Merriman Curhan Ford Buy 10/30/2008
    Susquehanna Financial Neutral Positive 10/27/2008
    Needham Hold Buy 09/26/2008 39.00
    JMP Securities Mkt Perform Mkt Outperform 09/25/2008 40.00
    Oppenheimer Outperform Perform 09/03/2008
    Leerink Swann Outperform 06/09/2008 40.00
    Susquehanna Financial Positive 06/06/2008 37.00
    Leerink Swann Outperform 06/05/2008 35.00
    Cowen & Co Neutral Outperform 06/05/2008
    JMP Securities Mkt Outperform Mkt Perform 06/04/2008
    Pacific Growth Equities Buy 05/21/2008
    Canaccord Adams Hold 04/28/2008 28.00
    Leerink Swann Outperform 04/25/2008
    JMP Securities Mkt Outperform 04/10/2008 30.00
    Robert W. Baird Neutral Outperform 04/01/2008 33.00
    Wachovia Underperform Mkt Perform 04/01/2008
    Susquehanna Financial Neutral Positive 03/31/2008
    Lazard Capital Sell Hold 03/12/2008
    Merriman Curhan Ford Neutral 03/11/2008
    Lazard Capital Sell 02/04/2008 13.00
    JMP Securities Mkt Outperform 01/29/2008